s6y
Company name or ticker
Search
ARS Pharmaceuticals, Inc.
4
Smith Margaret Ekins: Statement of changes in beneficial ownership of securities
Filed
Wednesday, September 2, 2026
Period
Sep 1, 2026
Accession number
0002149973-26-000004
Documents
form4-09022026_090920.xml
4
On sec.gov
Filing index
All files
Complete submission text
SGML header